Fig. 5From: In vivo assessment of neuroinflammation in progressive multiple sclerosis: a proof of concept study with [18F]DPA714 PETBinding potential for different regions of interest. For high-affinity binders, a higher binding potential (BPND) was seen in multiple sclerosis patients (MS-HAB) than in healthy controls (HC-HAB) for different regions of interest. This difference was not seen in medium-affinity binding (MAB) subjectsBack to article page